Alert Header goes here

Rutland Regional Medical Center

Be sure the class of "ShowPanel" is added to the div of "AlertPanel" or the panel will not show.

An image can be added. Be sure to add the class of "Left" or "Right" if the text should flow around it.

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Itaque hic eos quasi nisi adipisci voluptas maxime placeat atque fugiat doloremque sint modi necessitatibus ea impedit laborum, distinctio, totam, quo nihil.

Skip to Content

Lung-Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination

Objective

ECOG E5508 A Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC

Lung: The purpose of this study is to find out the best maintenance therapy for patients with advanced stage non-small cell lung cancer. Maintenance therapy is usually given after standard chemotherapy to keep the disease under control for a longer duration. This study will compare the effects, good and/or bad, of the drugs, bevacizumab, pemetrexed or the combination of the two agents when given as maintenance therapy.

Contact
Rebecca Denofer, RN, OCN at 802-747-1692
or rdenofer@rrmc.org

RUTLAND REGIONAL MEDICAL CENTER160 Allen Street, Rutland, VT 05701802.775.7111

© 2018 Rutland Medical Center